Adrian U Wiestner

USPTO Granted Patents = 7 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 15(Granted Patents)

Company Filing History:

7 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

2 out of 998

University of Virginia Patent Foundation

patents

where one patent can have more than one assignee

Years Active: 2008-2022

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11384139 - Antibody targeting cell surface deposited complement protein C3d and use thereof (2022-07-12),

2. 10035848 - Antibody targeting cell surface deposited complement protein C3d and use thereof (2018-07-31),

3. 8748114 - ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL) (2014-06-10),

4. 8637560 - Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment (2014-01-28),

5. 8518968 - Hydrazone and diacyl hydrazine compounds and methods of use (2013-08-27),

6. 7981610 - ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL) (2011-07-19),

7. 7329502 - ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) (2008-02-12),

Title: The Innovative Contributions of Adrian U Wiestner

Introduction

Adrian U Wiestner is a prominent inventor based in Bethesda, MD (US), known for his significant contributions to the field of biomedical research. With a total of 7 patents to his name, he has made remarkable strides in the development of therapies targeting cancer cells.

Latest Patents

Among his latest patents is an innovative approach involving an antibody that targets the cell surface deposited complement protein C3d. This anti-C3d antibody or antibody fragment is designed for use in methods that effectively kill cancer cells. The related methods and compositions further enhance the potential applications of this groundbreaking research.

Career Highlights

Adrian has had a distinguished career, working with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Virginia. His work in these institutions has allowed him to contribute to significant advancements in medical science.

Collaborations

Throughout his career, Adrian has collaborated with notable colleagues, including Louis M Staudt and Andreas Rosenwald. These partnerships have fostered an environment of innovation and have led to the development of impactful research.

Conclusion

Adrian U Wiestner's work exemplifies the spirit of innovation in the biomedical field. His patents and collaborations continue to pave the way for new therapeutic strategies against cancer.

This text is generated by artificial intelligence and may not be accurate.